Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel trial, marking an ...
At Narrow Creek Stud, success in the Thoroughbred industry is driven by specialisation and disciplined management. Owner John Everett rejects traditional diversification, focusing entirely on a ...
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...
Hormones—including androgens, estrogen, and cortisol—play a major role in hair growth and hair loss over time.
Four FUOYE academics secured ₦89.964 million in National Research Fund (NRF) grants for innovative research tackling critical ...
Company AnnouncementTopline results from Phase 3 EPCORE® DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated ...
Four academics at the Federal University Oye-Ekiti have secured a total of ₦89.964m in National Research Fund grants from the ...
Have you ever wondered why many South Indians naturally have curly hair? Discover the scientific reasons behind this unique ...
Four academics of the Federal University Oye-Ekiti (FUOYE) have secured a total of ₦89.964 million in National Research Fund (NRF) grants to undertake innovative research projects aimed at addressing ...
Four academics at the Federal University Oye-Ekiti (FUOYE) in Ekiti State, have secured a combined ₦89.964 million in ...
AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results